THE ROBERT DARBISHIRE PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: P84072 | MANCHESTER, M14 5NP
Showing results 451-500 of 661
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Moxonidine | 28 | 1,176 | £155 | -49.7% ▼ |
| 28 | 670 | £44 | +665.2% ▲ | |
| Amiodarone hydrochloride | 27 | 700 | £43 | -58.1% ▼ |
| Lacidipine | 27 | 952 | £80 | -77.4% ▼ |
| Ipratropium bromide | 27 | 623 | £261 | -6.1% ▼ |
| Erythromycin | 27 | 1,436 | £466 | -22.1% ▼ |
| Pilocarpine hydrochloride | 27 | 380 | £1.2K | +163.0% ▲ |
| Benzalkonium chloride | 27 | 9,250 | £206 | +135.4% ▲ |
| Valsartan/amlodipine | 26 | 728 | £619 | +137.0% ▲ |
| Bezafibrate | 26 | 734 | £126 | -51.7% ▼ |
| Rizatriptan | 26 | 237 | £542 | -56.3% ▼ |
| Febuxostat | 26 | 770 | £59 | -30.4% ▼ |
| Other sunscreening preparations | 26 | 4,625 | £299 | +231.7% ▲ |
| Aciclovir | 26 | 204 | £193 | +110.9% ▲ |
| 26 | 395 | £581 | +137.5% ▲ | |
| Metoprolol tartrate | 25 | 840 | £130 | -50.7% ▼ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 25 | 700 | £403 | +58.0% ▲ |
| Erythromycin ethylsuccinate | 25 | 2,872 | £483 | +7.1% ▲ |
| Ivermectin | 25 | 129 | £1.7K | +156.2% ▲ |
| Tibolone | 25 | 700 | £62 | -18.3% ▼ |
| Metronidazole | 25 | 1,055 | £374 | -33.5% ▼ |
| 25 | 260 | £636 | +59.3% ▲ | |
| Salmeterol | 24 | 24 | £717 | -0.2% vs avg |
| Amantadine hydrochloride | 24 | 2,086 | £562 | -13.8% ▼ |
| Sevelamer | 24 | 3,752 | £598 | +9.5% ▲ |
| Menthol | 24 | 11.2K | £399 | -14.8% ▼ |
| 24 | 286 | £55 | -39.1% ▼ | |
| Olmesartan medoxomil/hydrochlorothiazide | 23 | 868 | £382 | +132.0% ▲ |
| Desloratadine | 23 | 914 | £76 | -20.3% ▼ |
| Levocetirizine | 23 | 630 | £84 | +47.6% ▲ |
| Simple | 23 | 4,600 | £38 | +100.4% ▲ |
| Dexamethasone | 23 | 1,187 | £294 | -26.2% ▼ |
| Methyl salicylate | 23 | 1,050 | £94 | +171.9% ▲ |
| 23 | 1,303 | £1.2K | +174.5% ▲ | |
| 23 | 6,362 | £150 | -53.9% ▼ | |
| INR blood testing reagents | 22 | 696 | £2.0K | +192.0% ▲ |
| Colestyramine | 22 | 1,906 | £444 | -23.6% ▼ |
| Buspirone hydrochloride | 22 | 1,816 | £441 | -56.3% ▼ |
| Trihexyphenidyl hydrochloride | 22 | 2,356 | £1.1K | -22.4% ▼ |
| Biphasic insulin lispro | 22 | 208 | £1.3K | -48.8% ▼ |
| Magnesium aspartate | 22 | 2,086 | £1.9K | +45.3% ▲ |
| Clindamycin phosphate | 22 | 1,050 | £225 | +33.7% ▲ |
| Diclofenac sodium | 22 | 1,700 | £1.2K | -8.2% ▼ |
| Hydralazine hydrochloride | 21 | 1,428 | £73 | -50.2% ▼ |
| Ofloxacin | 21 | 560 | £745 | +155.6% ▲ |
| Saxagliptin | 21 | 588 | £631 | -37.2% ▼ |
| Calcium acetate | 21 | 1,782 | £144 | +13.5% ▲ |
| Xylometazoline hydrochloride | 21 | 495 | £124 | +265.8% ▲ |
| 21 | 370 | £4.9K | +100.9% ▲ | |
| 21 | 2,180 | £113 | -48.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.